RxDoctor Payments Data

Perry Hooper, DO

Orthopaedic Surgery · Montgomery, ALNPI 1609117266

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (58.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Smith+Nephew at 41.4% of the total. Reporting peaked in 2019 at $18,719 and has fallen 77.5% since, to $4,217 in 2025. Among orthopaedic surgery clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$35,874in general payments, 2019–2025

Across 120 payments — averaging $298.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$15K
  • Arthrex$9K
  • Prime Surgical, LLC$6K
  • Medical Device Business Services, Inc.$3K
  • Stryker$1K
  • Johnson & Johnson$413
  • plus $1K from 16 others

What the payments were for

  • Travel & lodging$11,11931%
  • Food & beverage$3,85111%
  • Education$20,90458%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$35,874 in reported general payments places this provider in the 90th percentile of 319 orthopaedic surgery providers in Alabama.

See all orthopaedic surgery providers in Alabama

Medicare billing

Part B allowed, 2024
$182,131
Medicare patients
306
Services billed
4,147

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen106$721
Meloxicam167$653
Celecoxib12$367
Pregabalin31$259
Cephalexin19$233
Naproxen57$223
Methocarbamol38$190
Methylprednisolone19$167
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen21$104
Tramadol Hcl36$90

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Montgomery

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →